There are different BCR-ABL1 fusion genes that are translated into proteins that are different
from each other, yet all leukemogenic, causing chronic myeloid leukemia (CML) or acute …

Chronic myelogenous leukemia (CML) in children is relatively rare. Because of a lack of
robust clinical study evidence, management of CML in children is not standardized and often …

With the improved survivals offered by the tyrosine kinase inhibitors has come the necessity
to address issues relating to quality of life and one such area is that of fertility and parenting …

Background The incidence of chronic myeloid leukemia (CML) increases with age, but it is
unclear how the characteristics of the disease vary with age. In children, where CML is very …

Background and objective: The characteristic chromosomal translocation t (9; 22)(q34; q11)
in chronic myeloid leukaemia (CML) mainly results in the two different BCR/ABL fusion …

All India Institute of Medical Sciences, New Delhi is an Apex Institute and caters to more than
1.5 million out-patients and 80,000 in-patients every year. In this study, we have presented …

Objective: The purpose of this study was to determine the clinical, biological, and molecular
characteristics at diagnosis in children and adolescents with chronic myelogenous leukemia …

Chronic myeloid leukemia (CML) is rare among children and adolescents. The early
molecular response (EMR) is an important prognostic significance for adult CML patients …

Background Chronic myeloid leukaemia (CML) is a haematopoietic stem cell disorder,
caused by a balanced reciprocal translocation (t (9; 22)(q34; q11)) that leads to the …

Chronic myelogenous leukemia (CML) is a rare disease in children, accounting for
approximately 3% of leukemias in children and adolescents, with an annual incidence of 1 …